These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6403596)

  • 1. Biochemical and histopathological studies on patients with mucopolysaccharidoses, two of whom had been treated by fibroblast transplantation.
    Crow J; Gibbs DA; Cozens W; Spellacy E; Watts RW
    J Clin Pathol; 1983 Apr; 36(4):415-30. PubMed ID: 6403596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A clinical trial of fibroblast transplantation for the treatment of mucopolysaccharidoses.
    Gibbs DA; Spellacy E; Tompkins R; Watts RW; Mowbray JF
    J Inherit Metab Dis; 1983; 6(2):62-81. PubMed ID: 6410119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical discrimination of Hurler and Scheie syndromes.
    Hopwood JJ; Muller V
    Clin Sci (Lond); 1979 Sep; 57(3):265-72. PubMed ID: 38945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of alpha-L-iduronidase activity in various tissues from two sibs affected with presumably the Hurler-Scheie compound syndrome.
    Thompson JN; Finley SC; Lorincz AE; Finley WH
    Birth Defects Orig Artic Ser; 1975; 11(6):341-6. PubMed ID: 811284
    [No Abstract]   [Full Text] [Related]  

  • 5. Properties of alpha-L-iduronidase in cultured skin fibroblasts from alpha-L-iduronidase-deficient patients.
    Fujibayashi S; Minami R; Ishikawa Y; Wagatsuma K; Nakao T; Tsugawa S
    Hum Genet; 1984; 65(3):268-72. PubMed ID: 6421718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proceedings: Alpha-L-iduronidase deficiency associated with chondroitin sulphate mucopolysaccharidosis.
    Babarik A; Benson PF; Dean MF; Muir H
    Arch Dis Child; 1975 Apr; 50(4):329-30. PubMed ID: 807169
    [No Abstract]   [Full Text] [Related]  

  • 7. Apparent allelism of the Hurler, Scheie, and Hurler/Scheie syndromes.
    Mueller OT; Shows TB; Opitz JM
    Am J Med Genet; 1984 Jul; 18(3):547-56. PubMed ID: 6433708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical spectrum of alpha-L-iduronidase deficiency.
    Roubicek M; Gehler J; Spranger J
    Am J Med Genet; 1985 Mar; 20(3):471-81. PubMed ID: 3922223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mucopolysaccharidoses and mucolipidoses.
    Kelly TE
    Clin Orthop Relat Res; 1976; (114):116-33. PubMed ID: 131015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. alpha-L-iduronidase deficiency and possible Hurler-Scheie genetic compound. Clinical, pathologic, and biochemical findings.
    Winters PR; Harrod MJ; Molenich-Heetred SA; Kirkpatrick J; Rosenberg RN
    Neurology; 1976 Nov; 26(11):1003-7. PubMed ID: 824566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. alpha-L-Iduronidase activity in established lymphoblastoid cells from patients with Hurler and Scheie syndromes transformed by Epstein-Barr virus.
    Minami R; Suzuki M; Kudoh T; Sato S; Oyanagi K
    Tohoku J Exp Med; 1977 Aug; 122(4):393-6. PubMed ID: 199964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variant of iduronidase deficient mucopolysaccharidoses: further evidence for genetic heterogeneity.
    Danes BS
    J Med Genet; 1977 Oct; 14(5):346-51. PubMed ID: 412969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of alpha-L-iduronidase activity determinations in leucocytes for the detection of Hurler and Scheie syndromes.
    Liem KO; Hooghwinkel GJ
    Clin Chim Acta; 1975 Apr; 60(2):259-62. PubMed ID: 805007
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical ultrastructural and tissue culture studies in a possible compound Hurler-Scheie case.
    Tondeur M; Vamos-Hurwitz E; Cantz M; Cremer N; Libert J; Pardou A
    Acta Paediatr Belg; 1976; 29(2):109-15. PubMed ID: 826105
    [No Abstract]   [Full Text] [Related]  

  • 15. The iduronidase-deficient mucopolysaccharidoses: clinical and roentgenorgraphic features.
    Stevenson RE; Howell RR; McKusick VA; Suskind R; Hanson JW; Elliott DE; Neufeld EF
    Pediatrics; 1976 Jan; 57(1):111-22. PubMed ID: 813180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the composition of urinary glycosaminoglycans and oligosaccharides in patients with mucopolysaccharidoses who were receiving fibroblast transplants.
    Purkiss P; Gibbs DA; Watts RW
    Clin Chim Acta; 1983 Jun; 131(1-2):109-21. PubMed ID: 6411385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of the mucopolysaccharidoses using cultured skin fibroblasts and amniotic fluid cells.
    Butterworth J
    J Inherit Metab Dis; 1978; 1(1):25-8. PubMed ID: 117232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Residual α-L-iduronidase activity in fibroblasts of mild to severe Mucopolysaccharidosis type I patients.
    Oussoren E; Keulemans J; van Diggelen OP; Oemardien LF; Timmermans RG; van der Ploeg AT; Ruijter GJ
    Mol Genet Metab; 2013 Aug; 109(4):377-81. PubMed ID: 23786846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Letter: Phenotypic variation in alpha-L-iduronidase deficiency.
    Leisti J; Rimoin DL; Kaback MM; Hollister DW; DEn Tandt W; Neufeld E; Matalon R; Philippart M
    Lancet; 1975 Jun; 1(7920):1344. PubMed ID: 49545
    [No Abstract]   [Full Text] [Related]  

  • 20. A canine model of human alpha-L-iduronidase deficiency.
    Spellacy E; Shull RM; Constantopoulos G; Neufeld EF
    Proc Natl Acad Sci U S A; 1983 Oct; 80(19):6091-5. PubMed ID: 6412235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.